Joshua Brown

Joshua Brown Pharm.D., Ph.D., M.S.


Department: Pharmaceutical Outcomes & Policy
Business Phone: (352) 294-8593
Business Email:

About Joshua Brown

Joshua Brown, Pharm.D., Ph.D., M.S., joined the department of pharmaceutical outcomes and policy as an assistant professor in 2016. He received his Doctor of Pharmacy and Master of Science degrees at the University of Arkansas for Medical Sciences in Little Rock, Arkansas, before pursuing a Ph.D. in pharmaceutical outcomes and policy at the University of Kentucky College of Pharmacy. During his doctoral training, Brown worked as the UK-Humana-Pfizer Research Fellow in a unique partnership between academic, managed care and pharmaceutical stakeholders. In his doctoral dissertation, he studied the utilization of vena cava filters for prevention of pulmonary embolism, focusing on the high utilization and low quality of care surrounding these devices, as well as the implementation of interventions to increase that quality of care. He has received funding from the PhRMA Foundation and the Food and Drug Administration to conduct a study on the comparative effectiveness and safety of oral anticoagulants. In 2017, Brown was named a Claude D. Pepper Junior Scholar and will conduct research in geriatric pharmacoepidemiology by linking existing clinical trial data to administrative claims. Brown has also received funding from the Hematology/Oncology Pharmacists Association to investigate treatment patterns and effectiveness in cancer-associated venous thromboembolism. Brown was also named a TEDMED Research Scholar in 2017 and has received a Young Investigator Award from the International Society for Thrombosis and Haemostasis in both 2016 and 2017.

Research Profile

Pharmacoepidemiology, health outcomes, drug policy and quality of care in hematology, cardiology and oncology



November 2017ACTIVE
Application of physiologically-based pharmacokinetic models to inform dosing recommendations for hormonal contraceptives co-administered with other medications
September 2017 – February 2019
Comparative effectiveness of direct-acting oral anticoagulants (DOACs) for stroke prevention in atrial fibrillation: Influence of study methods on the usefulness of the results in the real-world
PHRMA FOU · Principal Investigator
September 2014 – August 2018
A Model- and Systems-based Approach to Efficacy and Safety Questions Related to Generic Substitution
US FOOD AND DRUG ADMN · Project Manager


University of Kentucky
University of Arkansas for Medical Science
University of Arkansas for Medical Science
University of Arkansas